Factor X values as a means to assess the extent of oral anticoagulation in patients receiving antithrombin drugs.
Hoppensteadt
D A
DA
Dept. of Pathol., Loyola Univ. Med. Center, Maywood, IL 60153, USA.
Kahn
S
S
Fareed
J
J
D000284:Administration, Oral; D015906:Angioplasty, Balloon, Coronary; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D000991:Antithrombins / Q000008:administration & dosage / Q000627:therapeutic use*; D001120:Arginine / Q000031:analogs & derivatives; D001779:Blood Coagulation Factors / Q000032:analysis*; D001780:Blood Coagulation Tests / Q000379:methods*; D016903:Drug Monitoring / Q000379:methods*; D004359:Drug Therapy, Combination; D005170:Factor X / Q000032:analysis*; D005189:False Positive Reactions; D005260:Female; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D007202:Indicators and Reagents; D008297:Male; D010875:Pipecolic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D011517:Prothrombin Time; D012016:Reference Values; D015203:Reproducibility of Results; D013449:Sulfonamides; D013921:Thrombocytopenia / Q000097:blood / Q000188:drug therapy; D013927:Thrombosis / Q000097:blood / Q000188:drug therapy; D014859:Warfarin / Q000008:administration & dosage / Q000627:therapeutic use
D000925:Anticoagulants; D000991:Antithrombins; D001779:Blood Coagulation Factors; D007202:Indicators and Reagents; D010875:Pipecolic Acids; D013449:Sulfonamides; D014859:Warfarin; D005170:Factor X; D006493:Heparin; D001120:Arginine; C031942:argatroban